Shunho 2023 Annual Performance: Revenue Increase and Yilong Brand Expansion

Business by 2FIRSTS.ai
Apr.30.2024
Shunho 2023 Annual Performance: Revenue Increase and Yilong Brand Expansion
Shunho Share releases annual report: 2023 revenue up 1.01% to 1.425 billion yuan, net profit up 147.41% to 28.4 million yuan.

On April 30th, Shunho Co., Ltd. (SZ002565) released its annual performance report, stating that its operating income in 2023 was approximately 1.425 billion yuan, an increase of 1.01% year-on-year. The net profit attributable to shareholders of the listed company was approximately 28.4 million yuan, an increase of 147.41% year-on-year.

Shunho 2023 Annual Performance: Revenue Increase and Yilong Brand Expansion
2023 Annual Report | Image Source: Shunho Corporation

 

Shunho Group has announced that its subsidiary Shunho Yilong holds the rights for the pod brand (domestic sales), e-cigarette accessories brand (domestic sales), and the combination of pod and smoking accessories brand sales (domestic sales). The brand is named "Yilong". During the reporting period, the "Yilong" brand e-cigarette products from Shunho Yilong have successfully launched in some retail stores in Beijing, Shenzhen, and Shanghai. The company plans to continue promoting the "Yilong" products in more regions in the future.

 

As of now, the subsidiary Green New Peak has obtained the Tobacco Wholesale Production Enterprise License for the e-cigarette processing enterprise. The participating company Mei Zhong Lian has obtained the Tobacco Wholesale Production Enterprise License for the e-cigarette production enterprise. The company's subsidiary Shunho Yilong has obtained the Tobacco Wholesale Production Enterprise License for the e-cigarette brand holding enterprise for domestic sales.

 

Shunho Corporation stated that, while ensuring the steady development of its environmentally friendly packaging new materials and printing businesses, the company is actively researching and developing new types of tobacco compliance products in accordance with policy requirements. It is also concentrating resources on applying for e-cigarette licenses and continuously conducting research and development investments in industrial hemp new technologies, new products, and overall plant applications. This has enabled the company to transition from a single manufacturing industry to a diversified, multi-industry chain expansion, achieving a new development pattern.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Seoul to Fine Use of Liquid E-Cigarettes in No-Smoking Areas From April 24
Seoul to Fine Use of Liquid E-Cigarettes in No-Smoking Areas From April 24
Seoul will begin fining the use of all tobacco products, including liquid e-cigarettes, in no-smoking areas from April 24, when the revised Tobacco Business Act takes effect.
Apr.09 by 2FIRSTS.ai
Glas Says FDA Scientific Review Backed Several Flavored Products Before Senior Leaders Blocked Them
Glas Says FDA Scientific Review Backed Several Flavored Products Before Senior Leaders Blocked Them
Glas says newly released internal FDA records show agency scientific reviewers supported authorization for several flavored G2 products before senior leadership halted them. According to documents obtained through a Freedom of Information Act request, FDA’s Office of Science first recommended marketing authorization for all eight products in December 2025 and later supported six of them in February 2026. FDA ultimately authorized only the G2 device and one tobacco-flavored pod in March.
Apr.23 by 2FIRSTS.ai
Revised Tobacco Business Act to Take Effect in South Korea, Banning Online Sales of Liquid Vapes
Revised Tobacco Business Act to Take Effect in South Korea, Banning Online Sales of Liquid Vapes
South Korea’s Ministry of Health and Welfare will implement a partial revision of the Tobacco Business Act on April 24. The scope will expand from products made with “tobacco leaves” to all products manufactured with natural or synthetic nicotine. Synthetic nicotine liquid e-cigarettes, which had previously been treated as industrial products and were freely sold and advertised online, will from April 24 be subject to the same regulations as ordinary tobacco products.
Apr.23 by 2FIRSTS.ai
Acting CTP Director Says FDA Cut Premarket Tobacco Application Backlog by About 70% Over the Past Year
Acting CTP Director Says FDA Cut Premarket Tobacco Application Backlog by About 70% Over the Past Year
FDA Center for Tobacco Products Acting Director Bret Koplow said at the American Tobacco and Nicotine Forum that the agency has reduced its premarket tobacco application backlog by about 70% over the past year and eliminated the acceptance queue. He said FDA has reviewed about 27 million applications, but only a small number have been authorized, mainly because most submissions lacked the scientific data needed to demonstrate public health benefits.
Apr.23 by 2FIRSTS.ai
Imperial Brands Pulls myblu Vape Business From U.S., Citing Prolonged FDA Approval Process
Imperial Brands Pulls myblu Vape Business From U.S., Citing Prolonged FDA Approval Process
Imperial Brands said it will phase out its myblu vaping business in the United States, citing prolonged FDA approval timelines for new vape products. The company said it will instead focus on modern oral nicotine products in the U.S., including the expansion of its Zone brand and new flavors. While overall next-generation product revenue continued to grow, revenue from the category in the Americas declined sharply.
May.12
Azerbaijan Cancels E-Cigarette State Standard as Full Vape Ban Takes Effect on April 1
Azerbaijan Cancels E-Cigarette State Standard as Full Vape Ban Takes Effect on April 1
The Azerbaijan Institute of Standardization (AZSTAND) has announced the cancellation of state standard AZS 941:2023, “Electronic Cigarettes. General Technical Specifications.”Under legal amendments adopted on December 30, 2025, Azerbaijan has prohibited from April 1, 2026 the import, export, manufacture, storage, wholesale and retail sale, and use of e-cigarettes and their components.
Apr.07 by 2FIRSTS.ai